@Sunilsurana
hi Sunil,
i tried to register but first attempt failed and on subsequent attempts i am getting a prompt
Error : email already exists.
my email is manishinlucknow(at)gmail.com
kindly help
@Sunilsurana
hi Sunil,
i tried to register but first attempt failed and on subsequent attempts i am getting a prompt
Error : email already exists.
my email is manishinlucknow(at)gmail.com
kindly help
Omkar results out today.
Sales increased from 66 cr in q2 fy 15 to 101 cr in q2 fy 16.
Net profit increased from 6.4 to 9 crores.
Half yearly EPS is at 8.35. (There is an error in the figure of eps reported in the result put on bse)
Looks like the good times are continuing for the company.
total debt at 215 crores as compared to 200 crores as at end of q2 fy 15. (there's variation in long term and short term figures but overall figures are as put up here)
Promoter pleding continues.
disc: invested.
0.17% reduction over a quarter can be ignored i guess. Could be for personal reason?
Was covered by Value-picks blog also -
http://value-picks.blogspot.in/2013/02/the-curious-case-of-lactose-india.html
Promoters have also been reducing stake over last few quarters. Why?
Talwalkars have decided to expands beyond India. First strategic investment in neighboring Sri Lanka in Power World Gym having similar customer and margin profile. I think good use of QIP proceeds which would help to improve ROE. This is much better fit and use of investment than club JV. This should stock gets it "mojo" back.
Hi Aniket,
Thanks for appreciating the effort.
1) Margins have improved for 2 reasons -
a) Proportion of conversion sales have increased, if you observe sales have come down while EBIDTA has increased.
For eg FY 13 had sales of Rs 46cr & EBIDTA at Rs 3cr while, FY15 had sales of Rs 24cr and EBIDTA of Rs 5cr.
b) Increase in lactose capacity exclusively for Kerry (from 3500tons to 11000tons).
As of now Lactose India numbers include lactose exclusively done for Kerry and small work for sanofi (pls refer Mitin's reply above). Bigger kicker will be higher utlisation of kerry capacity and Lactulose (which will happen over next 2 years). Many companies outsource smaller ingredient or component work to specialists take for Eg AIA engineering...what AIA does (grinding balls) constitutes small ( in terms of cost) for mining and cement companies but AIA enjoys very good margins with almost monopoly. AIA cost is small and sticky for mining & cement companies. Lactose India with high market share and long history could have been chosen by kerry for similar reasons. Rs 10cr for Kerry would be too small, while they get supplies from Lactose India (Pls refer to Kerry transaction to understand)
2) Yes you are right contracts into these companies would require significant sales effort and track record. Lactose does have a track record and Kerry approached them for capacity expansion. According to management many of their clients insisted Lactose India to manufacture Lactulose (Lactulose is 3rd derivation from Lactose after processing...pls google further to understand the same). Thus Lactulose capacity has been put up after such requests/demand from clients.
Pls go through their site www.lactoseindialimited.com....it contains good info.
Hope that helps.
Thanks.
Another research report which went on to analyse the impact of the Lactose India acquisition on Kerry.
https://www.davy.ie/research/content/email/kygcr20111129.pdf
And very curiously , Kerry had announced in an notice to Ireland exchange in 2011, that they have acquired Lactose India
http://www.kerrygroup.com/docs/interim-management-statements/IMS/Q3_2011_IMS.pdf
and same was also reported in an Irish newspaper http://www.irishexaminer.com/business/kfqlojsncwau/
And again same was reported in 2011 AR of Kerry,
http://www.kerrygroup.com/docs/reports/2011/Kerry_Group_2011_Annual_Report.pdf
but Lactose India finds no mention in 2012 AR of Kerry http://www.kerrygroup.com/docs/reports/2012/Kerry_Group_2012_Annual_Report.pdf .
So officially it's part of Kerry group now
The business prospects appears good, but given this kind of mis-information, I doubt if promoter can be trusted ?
Hi folks,
Thanks for bringing this up here. Very educational & interesting. Had a couple of questions:
1. What exactly is the product and how are these margins justified?
The current financials (FY15) with 57% GM and 22% EBITDA sounds quite high. Even if one discounts the operating leverage, I couldn't understand such high GM levels. Prabhat Dairy manufactures some specialised milk-based ingredients for a global pharma client that does into their formulations. Even Prabhat earns 15%-odd margins here, and significantly lower for their other B2B clients.
2. Wallet Share, Bargaining Power
From a rough reading of your post, I understood that Kerry and Sanofi are effectively loaning money out to Lactose to set up capacity. Why would they do that and let Lactose earn high RoCEs? What wallet share does Lactose have among other suppliers for the same product in Kerry and Sanofi?
3. Promoter and Management
Contracts into these companies require significant sales effort and track record. It's unique to see a small-ish company achieve this break. Would love to get some background around the promoter and his ability to gain in-roads into these companies.
Best,
A
Thanks Anil for your kindness. Very obliged
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!